Wells Fargo & Company Issues Positive Forecast for National Health Investors (NYSE:NHI) Stock Price

National Health Investors (NYSE:NHI) had its price objective raised by Wells Fargo & Company from $85.00 to $86.00 in a research report released on Friday morning,Benzinga reports. The firm currently has an equal weight rating on the real estate investment trust’s stock.

Other analysts have also issued reports about the stock. National Bank Financial set a $85.00 target price on shares of National Health Investors in a research note on Tuesday, January 20th. Weiss Ratings restated a “buy (b)” rating on shares of National Health Investors in a research report on Monday, December 29th. KeyCorp increased their price objective on National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. Cantor Fitzgerald set a $85.00 price objective on National Health Investors in a research note on Monday, January 5th. Finally, Deutsche Bank Aktiengesellschaft cut National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 target price on the stock. in a report on Tuesday, January 20th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $86.83.

National Health Investors Trading Down 0.6%

Shares of NHI stock opened at $82.30 on Friday. The stock has a 50-day simple moving average of $84.55 and a 200 day simple moving average of $79.79. The stock has a market capitalization of $3.99 billion, a P/E ratio of 27.25, a P/E/G ratio of 4.49 and a beta of 0.65. National Health Investors has a fifty-two week low of $66.41 and a fifty-two week high of $91.38. The company has a quick ratio of 6.90, a current ratio of 6.90 and a debt-to-equity ratio of 0.76.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.01). National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.The business had revenue of $105.82 million during the quarter, compared to the consensus estimate of $95.12 million. During the same quarter last year, the firm posted $1.24 earnings per share. National Health Investors’s revenue was up 6.8% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, sell-side analysts expect that National Health Investors will post 4.41 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.92 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.5%. National Health Investors’s payout ratio is currently 121.85%.

Institutional Investors Weigh In On National Health Investors

Several hedge funds have recently bought and sold shares of NHI. Vanguard Group Inc. increased its holdings in shares of National Health Investors by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 6,498,414 shares of the real estate investment trust’s stock valued at $516,624,000 after purchasing an additional 52,474 shares during the period. State Street Corp boosted its holdings in shares of National Health Investors by 5.0% during the second quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock worth $143,651,000 after purchasing an additional 95,812 shares during the period. Principal Financial Group Inc. boosted its holdings in shares of National Health Investors by 1.9% during the fourth quarter. Principal Financial Group Inc. now owns 1,668,006 shares of the real estate investment trust’s stock worth $127,386,000 after purchasing an additional 30,968 shares during the period. JPMorgan Chase & Co. grew its position in National Health Investors by 34.0% during the third quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock valued at $128,238,000 after purchasing an additional 409,559 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in National Health Investors by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 1,262,657 shares of the real estate investment trust’s stock valued at $96,443,000 after buying an additional 18,198 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.